Polycystic Ovary Syndrome Research: A Scientometric Assessment of Global Publications Output During 2007-16

摘要

The paper examines 1829 global publications on polycystic ovary syndrome research, as covered in Scopus database during 2007-16, recording an annual average growth rate of -0.58% and citation impact averaged to 13.78 citations per paper. The top 10 most productive countries individually contributed global share from 4.05% and 18.21%, with largest global publication share coming from USA followed by U.K and China (9.57% and 9.40% share each), Italy (6.40%), Turkey (5.19% share), India, Iran, Greece, Egypt and France (from 4.05% to 4.54%) during 2006-17. Together, the 10 most productive countries accounted for 70.31% and 96.97% share of global publications and citation output during 2007-16. The national share of international collaborative papers across top 10 countries in polycystic ovary syndrome research varied from 4.21% to 32.00%, during 2007-16. Medicine accounting for the highest publications share (93.66%), followed by biochemistry, genetics & molecular biology (30.62%) and pharmacology, toxicology & pharmaceutics (3.72%) during 2007-16..The top 15 most productive organizations and authors together contributed 19.57% and 15.25% respectively as their share of global publication output and 51.06% and 49.79% respectively as their share of global citation output during 2007-16. Among the total journal output of 1793 papers, the top 15 journals contributed 37.20% share to the global journal output during 2007-16. Of the total global polycystic ovary syndrome research output, the top 27 highly cited publications registered citations from 100 to 727 and they together received 5556 citations, with 205.78 citations per paper. These 27 highly cited papers resulted from research pursuits of 124 authors and 92 organizations. These 27 highly cited papers appeared in 15 journals: Human Reproduction Update published 8 papers, 3 papers each in Fertility & Sterility and Human Reproduction, 2 papers each in Endocrine Reviews and Clinical Endocrinology, and 1 paper each in other journals.